Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA 2474649 A1 · Owner: Padigaru, Muralidhara · Inventors: Shimkets, Richard A.; Shenoy, Suresh G.; Rastelli, Luca
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences and , antibodies that immunospecifcally bind to the polypeptide as well as , derivatives, variants, mutants or fragments of the novel polypeptide, polynucleotide or antibody specific to the polypeptide. Vectors host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic diagnostic and research methods for , diagnosis treatment, and prevention of disorders involving any one of these novel human nucleic acids …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 3, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.